Plaque Inflammation and Dysfunctional HDL in AIM-HIGH (HDL Proteomics)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Listed as NCT00880178, this observational or N/A phase trial focuses on Atherosclerosis and Cardiovascular Diseases and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 11 times since 2008, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
May 2017 — Aug 2017 [monthly]
Completed NA
-
Jan 2017 — May 2017 [monthly]
Completed NA
First recorded
May 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Washington
For direct contact, visit the study record on ClinicalTrials.gov .